4.4 Article

Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting

Journal

DRUG AND ALCOHOL DEPENDENCE
Volume 183, Issue -, Pages 96-101

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2017.10.030

Keywords

Hepatitis C; People who inject drugs; Prisoners; Risk environment framework

Funding

  1. Gilead Sciences, Inc.
  2. Australian Government Department of Health and Ageing through a National Health and Medical Research Council (NHMRC) [APP1092547]
  3. Australian Government Department of Health and Ageing
  4. Australian Department of Health

Ask authors/readers for more resources

Background: Hepatitis C (HCV) is a blood-borne virus that is most commonly transmitted through shared injecting equipment. Due to the criminalisation of injecting drug use, HCV is highly prevalent among those incarcerated. Using a risk environment framework, this qualitative study sought to understand the role of HCV risk within injecting networks in the prison setting. Methods: Thirty-two adult prisoners (n = 24 men; n = 8 women) with a history of injecting drug use participated in this qualitative sub-study. Participants were recruited across four correctional centres. Results: Social, economic, and environmental risk factors contributed to injecting practices within prison. Commonly, the person supplying the drugs injected first, with the person who owns the injecting equipment going next. HCV did not regularly factor into determining order of injection within networks (i.e., first, second, third), although it was reported that some prisoners claimed not to have HCV in efforts to jump the queue. Conclusion: Social, economic, and environmental risk factors contribute to negotiation of injecting order among people who inject drugs in prison. Risk of HCV exposure rarely influenced the injecting order. Harm reduction strategies should consider the social factors influencing injecting drug use in the prison setting especially to optimise the population benefits of the roll-out of highly effective HCV treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting

Lise Lafferty, Jake Rance, Gregory J. Dore, Andrew R. Lloyd, Carla Treloar

Summary: Social capital, including bonding, bridging, and linking, plays a significant role in promoting hepatitis C treatment uptake within a treatment-as-prevention trial in male prisons. Specifically, bonding social capital encourages treatment uptake, bridging social capital supports widespread treatment acceptance in the prison, and linking social capital fosters trust in study personnel, thereby enhancing treatment engagement.

ADDICTION (2021)

Article Substance Abuse

Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C)

Jake Rance, Lise Lafferty, Carla Treloar

Summary: According to expert stakeholders' assessments of HCV treatment-as-prevention in Australian prisons, most believe in the universal rollout of direct-acting anti-virals, but express concerns about the lack of effective primary prevention in Australian prisons.

ADDICTION (2021)

Article Public, Environmental & Occupational Health

Establishing the impact of consumer participation in alcohol and other drug treatment settings in Australia

Loren Brener, Robyn Horwitz, Jake Rance, Rebecca Gray, Fiona Poeder, Joanne Bryant

Summary: Engaging consumers in AOD treatment is crucial, but faces challenges. Staff who participated in consumer participation training were more likely to believe service changes could encourage greater consumer participation. Most current consumer participation activities are at a low level, but there is support for higher levels of involvement.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2022)

Article Substance Abuse

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel

L. Lafferty, J. Rance, G. J. Dore, J. Grebely, A. R. Lloyd, C. Treloar

Summary: The study found that HCV treatment as prevention was widely accepted by correctional and prison health personnel, but environmental issues such as limited clinic space require a strategic approach to support prison-wide scale-up of HCV treatment.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Article Public, Environmental & Occupational Health

Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs

Loren Brener, Robyn Horwitz, Jake Rance, Theresa Caruana, Joanne Bryant

Summary: The COVID-19 pandemic has impacted staff working at harm reduction and alcohol and other drug services in Australia. However, they have been able to respond by implementing various measures such as modifying service delivery, taking on additional responsibilities for client safety, and implementing COVID-19 infection control strategies, thus ensuring continued service provision.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2022)

Article Substance Abuse

?You need a designated officer ?-Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting

L. Lafferty, J. Rance, M. Byrne, A. Milat, G. J. Dore, J. Grebely, A. R. Lloyd, C. Treloar

Summary: This study conducted a qualitative assessment of implementing HCV treatment-as-prevention in correctional centres and summarized the barriers and enablers faced by prison personnel.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

Review Public, Environmental & Occupational Health

What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review

Kerryn Drysdale, Jake Rance, Elena Cama, Carla Treloar, Limin Mao

Summary: Ageing with chronic viral hepatitis, particularly HBV and HCV, presents unique challenges in end-of-life care. Current literature primarily focuses on clinical aspects such as prognosis assessment and symptom management, while neglecting educative aspects and psychosocial interventions. The social and cultural dimensions of chronic viral hepatitis in the context of end-of-life are understudied.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2022)

Article Public, Environmental & Occupational Health

Practising care in a pandemic: Accounting for everyday life during COVID-19 among people who inject drugs

Jake Rance, Joanne Bryant, Theresa Caruana, Loren Brener

Summary: This article presents in-depth interviews conducted with people who inject drugs in urban and regional Australia during the COVID-19 pandemic. Surprisingly, many participants reported minimal disruption to their everyday lives and even improved well-being. The study examines how care was realized in the daily routines and practices of the participants, with insights from Foucault's ethics and feminist perspectives on the politics of care.

SOCIOLOGY OF HEALTH & ILLNESS (2023)

Article Gastroenterology & Hepatology

'There's too much power in this number. It's freaking the whole response out': The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia

Carla Treloar, Jake Rance, Joanne Bryant, Lise Lafferty

Summary: This study investigates key informants' understandings of the use of targets and evidence in driving action for hepatitis C elimination, using New South Wales as a case study. The findings reveal that achieving elimination may require experimental approaches beyond existing evidence, and determining the metrics for evaluating return on investment is a major concern. The study suggests that the understanding of the evidence and strategies for elimination is still unsettled and may require a shift from evidence-based to evidence-making paradigm.

JOURNAL OF VIRAL HEPATITIS (2023)

Article Public, Environmental & Occupational Health

Perceptions of COVID-19 Vaccines: Lessons from Selected Populations Who Experience Discrimination in the Australian Healthcare System

Daniel Storer, Lise Lafferty, Simon Graham, Dean Murphy, Jake Rance, Loren Brener, Holly Seale, Mohamed A. Hammoud, Garrett Prestage, Mitchell Beadman, Kristy Gardner, Megan Blaxland, Reuben Bolt, Theresa Caruana, Steven Philpot, John Rule, Joanne Bryant

Summary: This paper presents qualitative findings from in-depth interviews about COVID-19 vaccination conducted in Australia. The study includes four different populations who have experienced discrimination in healthcare settings: Aboriginal people, people who inject drugs, people living with HIV, and gay and bisexual men. The findings show that past experiences of discrimination can impact vaccine willingness, and promoting vaccination among these populations should consider their unique histories.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2023)

Article Public, Environmental & Occupational Health

Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limits

Jake Rance, Tim Rhodes, Kari Lancaster

Summary: This article explores how universal access to HCV treatment drugs affects the citizenship and social inclusion perceptions of people who inject drugs and others affected by HCV. Some narratives depict treatment as a citizenship potential, while others highlight limitations to its direct realization, emphasizing viral cure and neglecting the social disadvantages of injecting drug use.

HEALTH (2022)

Article Substance Abuse

Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C)

Jake Rance, Lise Lafferty, Carla Treloar

Summary: While concerns about the lack of primary prevention in Australian prisons were widespread among respondents, expert stakeholders showed broad levels of support for the intervention and the future scale-up of HCV treatment. Several key external and internal factors were identified, highlighting the importance of an enabling political-cum-policy environment and obtaining support from prisons' executive and custodial staff, among others.

HARM REDUCTION JOURNAL (2021)

Article Substance Abuse

Towards eliminating viral hepatitis: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination

Kari Lancaster, Tim Rhodes, Jake Rance

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

Article Substance Abuse

Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting

Lise Lafferty, Jake Rance, Jason Grebely, Gregory J. Dore, Andrew R. Lloyd, Carla Treloar

INTERNATIONAL JOURNAL OF DRUG POLICY (2020)

Article Public, Environmental & Occupational Health

'Behind closed doors, no one sees, no one knows': hepatitis C, stigma and treatment-as-prevention in prison

Jake Rance, Lise Lafferty, Carla Treloar

CRITICAL PUBLIC HEALTH (2020)

No Data Available